ID   CMT170
AC   CVCL_B492
SY   CMT-170; CMT 170
DR   CancerTools; 153332
DR   Wikidata; Q54813841
DR   Ximbio; 153332
RX   PubMed=6324836;
RX   PubMed=9347924;
RX   PubMed=19003861;
CC   Omics: Proteome analysis by 2D-DE/MS.
CC   Breed/subspecies: C57BL/ICRF-a(t).
DI   NCIt; C21771; Adenocarcinoma of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2405 ! CMT167
SX   Female
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 21-03-23; Version: 8
RX   PubMed=6324836; DOI=10.1038/bjc.1984.67;
RA   Layton M.G., Franks L.M.;
RT   "Heterogeneity in a spontaneous mouse lung carcinoma: selection and
RT   characterisation of stable metastatic variants.";
RL   Br. J. Cancer 49:415-421(1984).
RX   PubMed=9347924; DOI=10.1016/S0300-483X(97)00108-X;
RA   Malkinson A.M., Dwyer-Nield L.D., Rice P.L., Dinsdale D.;
RT   "Mouse lung epithelial cell lines -- tools for the study of
RT   differentiation and the neoplastic phenotype.";
RL   Toxicology 123:53-100(1997).
RX   PubMed=19003861; DOI=10.1002/pmic.200800299;
RA   Zhang K.-L., Wrzesinski K., Stephen J.F., Larsen P.M., Zhang X.-M.,
RA   Roepstorff P.;
RT   "Comparative proteome analysis of three mouse lung adenocarcinoma CMT
RT   cell lines with different metastatic potential by two-dimensional gel
RT   electrophoresis and mass spectrometry.";
RL   Proteomics 8:4932-4945(2008).